Urocortin 3 Levels Are Impaired in Overweight Humans With and Without Type 2 Diabetes and Modulated by Exercise
Urocortin3 (UCN3) regulates metabolic functions and is involved in cellular stress response. Although UCN3 is expressed in human adipose tissue, the association of UCN3 with obesity and diabetes remains unclear. This study investigated the effects of Type 2 diabetes (T2D) and increased body weight o...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2019-11-01
|
| Series: | Frontiers in Endocrinology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/article/10.3389/fendo.2019.00762/full |
| _version_ | 1828392390065389568 |
|---|---|
| author | Sina Kavalakatt Abdelkrim Khadir Dhanya Madhu Maha Hammad Sriraman Devarajan Jehad Abubaker Fahd Al-Mulla Jaakko Tuomilehto Jaakko Tuomilehto Jaakko Tuomilehto Ali Tiss |
| author_facet | Sina Kavalakatt Abdelkrim Khadir Dhanya Madhu Maha Hammad Sriraman Devarajan Jehad Abubaker Fahd Al-Mulla Jaakko Tuomilehto Jaakko Tuomilehto Jaakko Tuomilehto Ali Tiss |
| author_sort | Sina Kavalakatt |
| collection | DOAJ |
| description | Urocortin3 (UCN3) regulates metabolic functions and is involved in cellular stress response. Although UCN3 is expressed in human adipose tissue, the association of UCN3 with obesity and diabetes remains unclear. This study investigated the effects of Type 2 diabetes (T2D) and increased body weight on the circulatory and subcutaneous adipose tissue (SAT) levels of UCN3 and assessed UCN3 modulation by a regular physical exercise. Normal-weight (n = 37) and overweight adults with and without T2D (n = 98 and n = 107, respectively) were enrolled in the study. A subset of the overweight subjects (n = 39 for each group) underwent a supervised 3-month exercise program combining both moderate intensity aerobic exercise and resistance training with treadmill. UCN3 levels in SAT were measured by immunofluorescence and RT-PCR. Circulatory UCN3 in plasma was assessed by ELISA and was correlated with various clinical and metabolic markers. Our data revealed that plasma UCN3 levels decreased in overweight subjects without T2D compared with normal-weight controls [median; 11.99 (0.78–86.07) and 6.27 (0.64–77.04), respectively; p < 0.001], whereas plasma UCN3 levels increased with concomitant T2D [median; 9.03 (0.77–104.92) p < 0.001]. UCN3 plasma levels were independently associated with glycemic index; fasting plasma glucose and hemoglobin A1c (r = 0.16 and r = 0.20, p < 0.05, respectively) and were significantly different between both overweight, with and without T2D, and normal-weight individuals (OR = 2.11 [1.84–4.11, 95% CI] and OR = 2.12 [1.59–3.10, 95% CI], p < 0.01, respectively). Conversely, the UCN3 patterns observed in SAT were opposite to those in circulation; UCN3 levels were significantly increased with body weight and decreased with T2D. After a 3-month supervised exercise protocol, UCN3 expression showed a significant reduction in SAT of both overweight groups (2.3 and 1.6-fold change; p < 0.01, respectively). In conclusion, UCN levels are differentially dysregulated in obesity in a tissue-dependent manner and can be mitigated by regular moderate physical exercise. |
| first_indexed | 2024-12-10T07:19:01Z |
| format | Article |
| id | doaj.art-49a23bbb2cff475fb4cf043c8a079e6c |
| institution | Directory Open Access Journal |
| issn | 1664-2392 |
| language | English |
| last_indexed | 2024-12-10T07:19:01Z |
| publishDate | 2019-11-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Endocrinology |
| spelling | doaj.art-49a23bbb2cff475fb4cf043c8a079e6c2022-12-22T01:57:51ZengFrontiers Media S.A.Frontiers in Endocrinology1664-23922019-11-011010.3389/fendo.2019.00762471116Urocortin 3 Levels Are Impaired in Overweight Humans With and Without Type 2 Diabetes and Modulated by ExerciseSina Kavalakatt0Abdelkrim Khadir1Dhanya Madhu2Maha Hammad3Sriraman Devarajan4Jehad Abubaker5Fahd Al-Mulla6Jaakko Tuomilehto7Jaakko Tuomilehto8Jaakko Tuomilehto9Ali Tiss10Research Division, Biochemistry and Molecular Biology Department, Dasman Diabetes Institute, Kuwait City, KuwaitResearch Division, Biochemistry and Molecular Biology Department, Dasman Diabetes Institute, Kuwait City, KuwaitResearch Division, Biochemistry and Molecular Biology Department, Dasman Diabetes Institute, Kuwait City, KuwaitResearch Division, Biochemistry and Molecular Biology Department, Dasman Diabetes Institute, Kuwait City, KuwaitResearch Division, Dasman Diabetes Institute, Kuwait City, KuwaitResearch Division, Biochemistry and Molecular Biology Department, Dasman Diabetes Institute, Kuwait City, KuwaitResearch Division, Dasman Diabetes Institute, Kuwait City, KuwaitResearch Division, Dasman Diabetes Institute, Kuwait City, KuwaitDepartment of Public Health, University of Helsinki, Helsinki, FinlandDepartment of Public Health Solutions, National Institute for Health and Welfare, Helsinki, FinlandResearch Division, Biochemistry and Molecular Biology Department, Dasman Diabetes Institute, Kuwait City, KuwaitUrocortin3 (UCN3) regulates metabolic functions and is involved in cellular stress response. Although UCN3 is expressed in human adipose tissue, the association of UCN3 with obesity and diabetes remains unclear. This study investigated the effects of Type 2 diabetes (T2D) and increased body weight on the circulatory and subcutaneous adipose tissue (SAT) levels of UCN3 and assessed UCN3 modulation by a regular physical exercise. Normal-weight (n = 37) and overweight adults with and without T2D (n = 98 and n = 107, respectively) were enrolled in the study. A subset of the overweight subjects (n = 39 for each group) underwent a supervised 3-month exercise program combining both moderate intensity aerobic exercise and resistance training with treadmill. UCN3 levels in SAT were measured by immunofluorescence and RT-PCR. Circulatory UCN3 in plasma was assessed by ELISA and was correlated with various clinical and metabolic markers. Our data revealed that plasma UCN3 levels decreased in overweight subjects without T2D compared with normal-weight controls [median; 11.99 (0.78–86.07) and 6.27 (0.64–77.04), respectively; p < 0.001], whereas plasma UCN3 levels increased with concomitant T2D [median; 9.03 (0.77–104.92) p < 0.001]. UCN3 plasma levels were independently associated with glycemic index; fasting plasma glucose and hemoglobin A1c (r = 0.16 and r = 0.20, p < 0.05, respectively) and were significantly different between both overweight, with and without T2D, and normal-weight individuals (OR = 2.11 [1.84–4.11, 95% CI] and OR = 2.12 [1.59–3.10, 95% CI], p < 0.01, respectively). Conversely, the UCN3 patterns observed in SAT were opposite to those in circulation; UCN3 levels were significantly increased with body weight and decreased with T2D. After a 3-month supervised exercise protocol, UCN3 expression showed a significant reduction in SAT of both overweight groups (2.3 and 1.6-fold change; p < 0.01, respectively). In conclusion, UCN levels are differentially dysregulated in obesity in a tissue-dependent manner and can be mitigated by regular moderate physical exercise.https://www.frontiersin.org/article/10.3389/fendo.2019.00762/fullurocortinUCN3CRFobesitydiabetesexercise |
| spellingShingle | Sina Kavalakatt Abdelkrim Khadir Dhanya Madhu Maha Hammad Sriraman Devarajan Jehad Abubaker Fahd Al-Mulla Jaakko Tuomilehto Jaakko Tuomilehto Jaakko Tuomilehto Ali Tiss Urocortin 3 Levels Are Impaired in Overweight Humans With and Without Type 2 Diabetes and Modulated by Exercise Frontiers in Endocrinology urocortin UCN3 CRF obesity diabetes exercise |
| title | Urocortin 3 Levels Are Impaired in Overweight Humans With and Without Type 2 Diabetes and Modulated by Exercise |
| title_full | Urocortin 3 Levels Are Impaired in Overweight Humans With and Without Type 2 Diabetes and Modulated by Exercise |
| title_fullStr | Urocortin 3 Levels Are Impaired in Overweight Humans With and Without Type 2 Diabetes and Modulated by Exercise |
| title_full_unstemmed | Urocortin 3 Levels Are Impaired in Overweight Humans With and Without Type 2 Diabetes and Modulated by Exercise |
| title_short | Urocortin 3 Levels Are Impaired in Overweight Humans With and Without Type 2 Diabetes and Modulated by Exercise |
| title_sort | urocortin 3 levels are impaired in overweight humans with and without type 2 diabetes and modulated by exercise |
| topic | urocortin UCN3 CRF obesity diabetes exercise |
| url | https://www.frontiersin.org/article/10.3389/fendo.2019.00762/full |
| work_keys_str_mv | AT sinakavalakatt urocortin3levelsareimpairedinoverweighthumanswithandwithouttype2diabetesandmodulatedbyexercise AT abdelkrimkhadir urocortin3levelsareimpairedinoverweighthumanswithandwithouttype2diabetesandmodulatedbyexercise AT dhanyamadhu urocortin3levelsareimpairedinoverweighthumanswithandwithouttype2diabetesandmodulatedbyexercise AT mahahammad urocortin3levelsareimpairedinoverweighthumanswithandwithouttype2diabetesandmodulatedbyexercise AT sriramandevarajan urocortin3levelsareimpairedinoverweighthumanswithandwithouttype2diabetesandmodulatedbyexercise AT jehadabubaker urocortin3levelsareimpairedinoverweighthumanswithandwithouttype2diabetesandmodulatedbyexercise AT fahdalmulla urocortin3levelsareimpairedinoverweighthumanswithandwithouttype2diabetesandmodulatedbyexercise AT jaakkotuomilehto urocortin3levelsareimpairedinoverweighthumanswithandwithouttype2diabetesandmodulatedbyexercise AT jaakkotuomilehto urocortin3levelsareimpairedinoverweighthumanswithandwithouttype2diabetesandmodulatedbyexercise AT jaakkotuomilehto urocortin3levelsareimpairedinoverweighthumanswithandwithouttype2diabetesandmodulatedbyexercise AT alitiss urocortin3levelsareimpairedinoverweighthumanswithandwithouttype2diabetesandmodulatedbyexercise |